Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
The Inner Mitochondrial Membrane01:28

The Inner Mitochondrial Membrane

The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria.  In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging Subspecialties in Neurology: Cortical Career as Neurology Program Director.

Neurology·2025
Same author

Reduction of opioid and barbiturate use following initiation of rimegepant for migraine in the United States.

Headache·2025
Same author

Education Research: Trends in the National Resident Matching Program Headache Medicine Match Data: A Retrospective Observational Study.

Neurology. Education·2025
Same author

Alcohol as a trigger of migraine attacks in people with migraine. Results from a large prospective cohort study in English-speaking countries.

Headache·2022
Same author

Headache Education Adaptation During the COVID-19 Pandemic: Impact on Undergraduate and Graduate Medical Education.

Current pain and headache reports·2022
Same author

Headache fellowship match shareholder insights.

Headache·2022
Same journal

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026
Same journal

American Headache Society 68th Annual Scientific Meeting June 4-7, 2026, Orlando, Florida.

Headache·2026
Same journal

In Memoriam-Doctor J. Keith Campbell.

Headache·2026
Same journal

Hypothalamus as a conductor of the migraine prodrome: A narrative review.

Headache·2026
Same journal

New academic year in Headache.

Headache·2026
Same journal

Essential readings in headache medicine: Top 10 educational articles from 2025.

Headache·2026
See all related articles

Related Experiment Video

Updated: Jul 5, 2026

Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy
07:47

Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy

Published on: July 9, 2016

Headache and mitochondrial disorders.

Noah Rosen1

  • 1Headache Center, North Shore-Long Island Jewish Health System Hospital and the Harvey Cushing Institutes of Neuroscience, USA.

Headache
|May 13, 2008
PubMed
Summary
This summary is machine-generated.

Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) is a distinct syndrome characterized by specific neurological and muscle abnormalities. Further research is needed to elucidate the precise biochemical defects in MELAS and related mitochondrial disorders.

More Related Videos

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Related Experiment Videos

Last Updated: Jul 5, 2026

Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy
07:47

Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy

Published on: July 9, 2016

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) is a rare genetic disorder.
  • Patients present with a constellation of symptoms including neurological deficits and muscle abnormalities.
  • Distinguishing MELAS from similar mitochondrial disorders is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To describe the clinical features of patients with MELAS.
  • To differentiate MELAS from Kearns-Sayre syndrome and myoclonus epilepsy ragged red fiber syndrome.
  • To highlight the potential maternal inheritance pattern of MELAS.

Main Methods:

  • Clinical case reporting of 2 patients with MELAS.
  • Review of previously reported cases (9 patients).
  • Analysis of clinical features including muscle biopsy findings (ragged red fibers), developmental history, stature, and neurological manifestations.

Main Results:

  • Patients with MELAS exhibit ragged red fibers on muscle biopsy, normal early development, short stature, seizures, and neurological deficits (hemiparesis, hemianopia, cortical blindness).
  • Lactic acidemia is a common biochemical finding in MELAS.
  • MELAS can be distinguished from Kearns-Sayre syndrome and myoclonus epilepsy ragged red fiber syndrome based on distinct clinical presentations.

Conclusions:

  • MELAS represents a distinct clinical syndrome with characteristic features.
  • Maternal inheritance is suggested for MELAS.
  • While ragged red fibers indicate electron transport system abnormalities, the specific biochemical defects in MELAS and related syndromes require further elucidation.